Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
119 participants
INTERVENTIONAL
2023-05-17
2025-01-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community Based Obesity Prevention Among Black Women
NCT00938535
A Weight-Loss Program in Helping Obese Black Women Lose Weight
NCT00859989
TOPS for African American Breast Cancer Survivors
NCT04741802
Preventing Weight Gain in African American Reproductive-Aged Women
NCT02416921
Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic
NCT03202420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Take Off Pounds Sensibly (TOPS)
This group will receive TOPS intervention at the start of the study.
Take of Pounds Sensibly (TOPS)
Dietician-facilitated classes
Waitlist control
This group will be the control group for 6 months. Then at the completion of the study they will receive the vouchers to participate in TOPS chapters in the community.
Waitlist Control
At end of study, offered peer-led classes to attend.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Take of Pounds Sensibly (TOPS)
Dietician-facilitated classes
Waitlist Control
At end of study, offered peer-led classes to attend.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥27 kg/m2
* Stable body weight (± 2 kg for 6 months prior to study)
* Sedentary (not exercising more than 1 hour per week)
* Must have a primary care provider and provide contact information
Participants with type 2 diabetes on insulin or sulfonylureas will be allowed to participate in the study only if their providers agree to manage the changing medications requirements associated with possible weight loss by signing a "Permission to Participate" form. It is important to include patients with type 2 diabetes on insulin and sulfonylureas because these participants can benefit greatly from weight loss.
Exclusion Criteria
* current cancer diagnosis
* Provider did not approve participation
* use of medications thought to effect metabolism, body weight, energy expenditure, or appetite
* major psychiatric disorder
* current moderate to severe symptoms of depression
* dementia
* neurological conditions causing functional limitations
* unstable medical illness such as unstable angina, recent MI, or congestive heart failure class III-IV
* terminal medical conditions
* Currently enrolled in a weight loss program
55 Years
99 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nia S Mitchell, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00100588
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.